Company news

Share this content:
Pfizer announced that it has completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals through a merger of Pfizer's wholly owned subsidiary, Explorer Acquisition Corp. 
Share this content:
Scroll down to see the next article